Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 9NIH 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 114Head and Neck Neoplasms 98Thyroid Neoplasms 55Salivary Gland Neoplasms 55Oropharyngeal Neoplasms 35Mouth Neoplasms 33Tongue Neoplasms 30Thyroid Cancer, Papillary 26Laryngeal Neoplasms 26Adenocarcinoma, Follicular 23Nasopharyngeal Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms 21Hypopharyngeal Neoplasms 20Uterine Cervical Neoplasms 19Colonic Neoplasms 19Carcinoma, Medullary 16Rectal Neoplasms 15Pancreatic Neoplasms 15Esthesioneuroblastoma, Olfactory 15Esophageal Neoplasms 15Anus Neoplasms 15Neoplasms 14Lung Neoplasms 14Thyroid Carcinoma, Anaplastic 13Stomach Neoplasms 13Melanoma 13Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11

Interventions

Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Hearing Loss × Head & Neck × Clear all
NCT04915183 2026-05-22

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
224 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT06303180 2025-11-14

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

National Institutes of Health Clinical Center (CC)

Recruiting
1,000 enrolled
Head & Neck

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Speech, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡